Key statistics
On Friday, Kyverna Therapeutics Inc (KYTX:NSQ) closed at 6.39, 1.43% above its 52-week low of 6.30, set on Sep 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.92 |
---|---|
High | 6.92 |
Low | 6.30 |
Bid | 6.35 |
Offer | 8.11 |
Previous close | 6.92 |
Average volume | 408.74k |
---|---|
Shares outstanding | 43.15m |
Free float | 38.49m |
P/E (TTM) | -- |
Market cap | 275.71m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Kyverna Therapeutics Presents Patient Data Reinforcing Potential of KYV-101 for Treatment of Neuroinflammatory Diseases in Symposium at ECTRIMS 2024
- Kyverna Therapeutics Announces Leadership Update
- Kyverna Therapeutics to Participate in Upcoming September Investor Conferences
- Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
- Kyverna Therapeutics Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Progressive Myasthenia Gravis
- Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome
More ▼